Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10897 |
CT-721
|
Others | Others |
CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase and has anti-chronic myeloid leukemia (CML) activity. |